Deep Medicine Acquisition Corp. (DMAQU) News
Filter DMAQU News Items
DMAQU News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Latest DMAQU News From Around the Web
Below are the latest news stories about Deep Medicine Acquisition Corp that investors may wish to consider to help them evaluate DMAQU as an investment opportunity.
Deep Medicine Acquisition Corp. Completes Upsized $126,500,000 Initial Public Offering, Including Full Exercise of Over-Allotment OptionNew York, NY, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (Nasdaq: DMAQU) (the “Company”) today announced the closing of its upsized initial public offering of 12,650,000 units at a price to the public of $10.00 per unit, which includes 1,650,000 units issued pursuant to the underwriters’ exercise of over-allotment option in full, with the offering raising gross proceeds of $126,500,000. The units commenced trading on Wednesday, October 27, 2021, on The Nasdaq Global Market |
Deep Medicine Acquisition Corp. Announces Pricing of Upsized $110 Million Initial Public OfferingNew York, NY, Oct. 26, 2021 (GLOBE NEWSWIRE) -- Deep Medicine Acquisition Corp. (the “Company”) announced today that it priced its upsized initial public offering of 11,000,000 units at $10.00 per unit. The units are expected to be listed on The Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “DMAQU” beginning October 27, 2021. Each unit consists of one share of Class A common stock and one right to receive one-tenth of one share of Class A common stock upon the consummation of |